BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16621146)

  • 1. Interaction of the tachykinin NK3 receptor agonist senktide with behavioral effects of cocaine in marmosets (Callithrix penicillata).
    de Souza Silva MA; Mello EL; Müller CP; Jocham G; Maior RS; Huston JP; Tomaz C; Barros M
    Peptides; 2006 Sep; 27(9):2214-23. PubMed ID: 16621146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys.
    De Souza Silva MA; Mello EL; Müller CP; Jocham G; Maior RS; Huston JP; Tomaz C; Barros M
    Eur J Pharmacol; 2006 May; 536(3):269-78. PubMed ID: 16603151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of hypervigilance effects of cocaine can be induced by NK3 receptor activation in marmoset monkeys.
    Melamed JL; de Souza Silva MA; Tomaz C; Müller CP; Huston JP; Barros M
    Drug Alcohol Depend; 2013 Feb; 128(1-2):155-60. PubMed ID: 23062871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects.
    Jocham G; Lauber AC; Müller CP; Huston JP; de Souza Silva MA
    Eur J Neurosci; 2007 Apr; 25(8):2457-72. PubMed ID: 17445241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin1A-receptor antagonism blocks psychostimulant properties of diethylpropion in marmosets (Callithrix penicillata).
    Mello EL; Maior RS; Carey RJ; Huston JP; Tomaz C; Müller CP
    Eur J Pharmacol; 2005 Mar; 511(1):43-52. PubMed ID: 15777778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NK3 receptor agonist senktide ameliorates scopolamine-induced deficits in memory for object, place and temporal order.
    Schäble S; Huston JP; Barros M; Tomaz C; de Souza Silva MA
    Neurobiol Learn Mem; 2012 Feb; 97(2):235-40. PubMed ID: 22209911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraventricular injections of tachykinin NK3 receptor agonists suppress the intake of "salty" tastes by sodium deficient rats.
    Flynn FW
    Behav Brain Res; 2006 Jan; 166(1):1-8. PubMed ID: 16154648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central injection of senktide, an NK3 receptor agonist, or neuropeptide Y inhibits LH secretion and induces different patterns of Fos expression in the rat hypothalamus.
    Sandoval-Guzmán T; Rance NE
    Brain Res; 2004 Nov; 1026(2):307-12. PubMed ID: 15488494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of senktide-induced tail whips.
    Nordquist RE; Ballard TM; Algeyer B; Pauly-Evers M; Ozmen L; Spooren W
    Neuropharmacology; 2010 Jan; 58(1):259-67. PubMed ID: 19540857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
    Yip J; Chahl LA
    Br J Pharmacol; 1997 Oct; 122(4):715-25. PubMed ID: 9375969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice.
    Ukai M; Shinkai N; Kameyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):97-101. PubMed ID: 8905797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine.
    Bealer SL; Flynn FW
    Exp Neurol; 2003 Dec; 184(2):1027-33. PubMed ID: 14769397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice.
    Nordquist RE; Savignac H; Pauly-Evers M; Walker G; Knoflach F; Borroni E; Glaentzlin P; Bohrmann B; Messer J; Ozmen L; Albientz A; Spooren W
    Behav Pharmacol; 2008 Sep; 19(5-6):518-29. PubMed ID: 18690106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurokinin3-R agonism in aged rats has anxiolytic-, antidepressant-, and promnestic-like effects and stimulates ACh release in frontal cortex, amygdala and hippocampus.
    Schäble S; Topic B; Buddenberg T; Petri D; Huston JP; de Souza Silva MA
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):484-94. PubMed ID: 21342754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer.
    Jordan RE; Smart D; Grimson P; Suman-Chauhan N; McKnight AT
    Br J Pharmacol; 1998 Oct; 125(4):761-6. PubMed ID: 9831912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective tachykinin NK3-receptor agonists stimulate in vitro exocrine pancreatic secretion in the guinea pig.
    Linari G; Broccardo M; Nucerito V; Improta G
    Peptides; 2002 May; 23(5):947-53. PubMed ID: 12084527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurokinin receptor modulation of respiratory activity in the rabbit.
    Bongianni F; Mutolo D; Cinelli E; Pantaleo T
    Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraventricular injections of tachykinin NK3 receptor agonist reduce the gain of the baroreflex in unrestrained rats.
    Flynn FW
    Exp Neurol; 2005 May; 193(1):118-24. PubMed ID: 15817270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.